Tandem Diabetes Care (TNDM) PT Raised to $57 at Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Tandem Diabetes Care (TNDM) PT Raised to $57 at Oppenheimer

Tandem Diabetes Care (TNDM) PT Raised to $56 at Piper Jaffray

September 26, 2018 6:20 AM EDT

Piper Jaffray analyst JP McKim raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $56.00 (from $32.00) while maintaining a Overweight rating.

... More

Pre-Open Movers 09/25: (ASNA) (TLRY) (NIHD) Higher; (TGTX) (OPNT) (SNDX) Lower (more...)

September 25, 2018 9:29 AM EDT

Today's Pre-Open Movers

TG Therapeutics (NASDAQ: TGTX) 27.6% LOWER; announced that the independent Data Safety Monitoring Board (DSMB) for the UNITY-CLL Phase 3 trial met to review ongoing data from the study and advised the Company that the interim analysis of Overall... More

Tandem Diabetes (TNDM) Raises FY18 Sales Guidance

September 25, 2018 9:02 AM EDT

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM) announced that it has increased its 2018 sales guidance to $150 million to $158 million, from $140 million to $148 million (*** consensus is $146.8 million), following continued strong domestic sales in the third quarter and the recent launch of the t:slim X2 Insulin Pump in select international markets. Compared to 2017 sales of approximately $108 million, the revised guidance... More